Delivery Order SPE2DB25D3404-SPE2DB25FUMXA

Award Date 4/10/25
Potential Completion Date 4/11/25
Potential Value $4.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,560,074,952 units of Doxycycline Hyclate 100mg tablets. The $2,209.34 firm fixed-price contract has a period of performance through February 28, 2023. This order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., valued at up to $999,999,999.00 and running through November...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,338,659 units of Doxycycline Hyclate 100 mg tablets, a generic antibiotic medication, with a ceiling value of $2,551.68. The contract is a Firm Fixed Price Delivery Order, with a period of performance through February 24, 2025. This contract is not designated as a set-aside...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,842,809 units of Doxycycline Hyclate 100 mg tablets, with a ceiling value of $1,093.88. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of April 9, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) to supply 4,568,288,330 units of 100mg doxycycline tablets. The $13,875.13 firm fixed-price contract has a completion date of June 16, 2025 and is not set aside. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, to provide a comprehensive range of pharmaceutical...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,567,482,551 units of Doxycycline Hyclate 100 mg tablets, a common antibiotic medication. The contract has a ceiling value of $2,126.40 and an ultimate completion date of March 7, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,895.03 firm fixed price contract is for the delivery of 4,566,895,400 doxycycline 50 mg tablets. The contract has an ultimate completion date of January 13, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,724.32, is for the delivery of 4,567,201,863 units of Doxycycline Hyclate 100 mg tablets, with a period of performance through February 10, 2025. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen holds a larger...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The $1,952.44 contract is for the delivery of 4,564,204,079 units of doxycycline hyclate 100mg tablets. The contract has an ultimate completion date of April 9, 2024. This delivery order is issued under an Indefinite Delivery Contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,275.79 firm fixed-price contract is for the delivery of 4,558,471,599 Doxycycline Hyclate 100 mg tablets. The contract has a period of performance ending on September 16, 2022. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract is for the supply of 4,564,442,679 units of doxycycline 100mg tablets, a common antibiotic medication. The delivery order has a firm fixed price of $1,233.12 and a completion date of April 30, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
  • SPE2DB25D3404
    Indefinite Delivery Contract
  • SPE2DB25D3404-SPE2DB25FUMXA
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,567,875,575 units of Doxycycline Hyclate 100 mg tablets. The contract has a ceiling value of $4,147.32 and a period of performance through April 11, 2025. It is a firm-fixed price delivery order contract, with no set-aside designation, indicating open competition.

AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This delivery order contract is likely part of the company's broader support to military and veteran healthcare systems through the DLA IDC.

Generated 7/17/25, 6:23 PM